Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lym phoma

被引：0
作者：
Muldoon, Leslie L. [1 ]
Lewin, Seth J. [1 ]
Dosa, Edit [1 ]
Pagel, Michael A. [1 ]
Doolittle, Nancy D. [1 ]
Neuwelt, Edward A. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5529
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5529
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Anti-cd20 therapy prevents cortical demyelination in a new rat model
    Haindl, M. T.
    Ucal, M.
    Togl, L.
    Klaus, B.
    Dohrmann, J.
    Adzemovic, M.
    Enzinger, C.
    Hochmeister, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 564 - 565
  • [32] Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (Rituximab).
    Musette, P
    Mouquet, H
    Jacquot, S
    Gilbert, D
    Huetz, F
    Roujeau, JC
    D'Incan, M
    Doutre, MS
    Gorin, I
    Caux, F
    Bedane, C
    Oro, S
    Tron, F
    Joly, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (06) : A16 - A16
  • [33] Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (Rituximab)
    Musette, P
    Mouquet, H
    Jacquot, S
    Gilbert, D
    Huetz, F
    Roujeau, JC
    D'Incan, M
    Tron, F
    Joly, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A13 - A13
  • [34] Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (rituximab)
    Musette, P.
    Mouquet, H.
    Jacquot, S.
    Gilbert, D.
    Gougeon, M. L.
    Roujeau, J. C.
    D'Incan, M.
    Bedane, C.
    Tron, F.
    Joly, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 23 - 23
  • [35] Complement activation and resistance within the CSF following intraventricular administration of anti-CD20 in the treatment of central nervous system lymphoma
    Kadoch, Cigall
    Karrim, Juliana
    Shuman, Marc
    Rubenstein, James
    NEURO-ONCOLOGY, 2007, 9 (04) : 510 - 510
  • [36] The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders
    Musto, Pellegrino
    D'Auria, Fiorella
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (05) : 551 - 557
  • [37] Combination monoclonal antibody therapy for lymphoma: Treatment with epratuzumab (anti-CD22) and rituximab (anti-CD20) is well tolerated.
    Leonard, JP
    Coleman, M
    Matthews, JC
    Fiore, JM
    Dosik, A
    Kapushoc, H
    Kin, E
    Cesano, A
    Wegener, WA
    Goldenberg, DM
    BLOOD, 2001, 98 (11) : 844A - 844A
  • [38] Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
    Zeng, Zhiyong
    Yang, Apeng
    Yang, Jingke
    Zhang, Sheng
    Xing, Zhen
    Wang, Xingfu
    Mei, Wenzhong
    Jiang, Changzhen
    Lin, Junfang
    Wu, Xiyue
    Xue, Yihui
    Wu, Zanyi
    Yu, Lianghong
    Wang, Dengliang
    Chen, Jianwu
    Zheng, Shufa
    Lin, Qiaoxian
    Chen, Qingjiao
    Dong, Jinfeng
    Zheng, Xiaoqiang
    Wang, Jizhen
    Huang, Jinlong
    Chen, Zhenying
    Chen, Ping
    Zheng, Meihong
    Zhou, Xiaofang
    He, Youwen
    Lin, Yuanxiang
    Chen, Junmin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [39] Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab
    Weitz, IC
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (02) : 138 - 141
  • [40] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
12345